DRUG-INDUCED CHRONIC LIVER DISEASE

Babany, 1987, Chronic active hepatitis caused by benzarone, J Hepatol, 5, 332, 10.1016/S0168-8278(87)80039-9 Babany, 1986, Chronic liver disease after low daily doses of amiodarone: Report of three cases, J Hepatol, 3, 228, 10.1016/S0168-8278(86)80031-9 Banks, 1995, Diclofenac-associated hepatotoxicity: Analysis of 180 cases reported to the Food and Drug Administration as adverse reactions, Hepatology, 22, 820, 10.1002/hep.1840220320 Bass NM, Ockner RK: Drug-induced liver disease. In Hepatology: A Textbook of Liver Disease, ed 3. Zakim D, Boyer T (eds): Philadelphia, WB Saunders Beaune, 1987, Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug, Proc Nat Acad Sci USA, 84, 551, 10.1073/pnas.84.2.551 Ben-Yahia, 1993, Chronic active hepatitis and cirrhosis induced by wild germander: Three cases, Gastroenterol Clin Biol, 17, 959 Bernard, 1994, Chronic active hepatitis associated with antinuclear antibodies induced by fenofibrate, Gastroenterol Clin Biol, 18, 1048 Black, 1975, Isoniazid-associated hepatitis in 144 patients, Gastroenterology, 69, 289, 10.1016/S0016-5085(19)32568-5 Black, 1980, Nitrofurantoin-induced chronic active hepatitis, Ann Intern Med, 92, 62, 10.7326/0003-4819-92-1-62 Bonkowski, 1978, Chronic hepatic inflammation and fibrosis due to low doses of paracetomol, Lancet, 1, 1016, 10.1016/S0140-6736(78)90740-7 Bourdi, 1992, Anti-liver microsome autoantibodies and dihydralazine-induced hepatitis: Specificity of autoantibodies and inductive capacity of the drug, Molec Pharmacol, 42, 280 Braillon, 1983, Hepatite aigue a la clometacine. Interet du dosage des anticorps anti-noyaux it anti-muscle lisse, Gastroenterol Clin Biol, 7, 318 Bremnes, 1991, Acute hepatotoxicity after high-dose methotrexate administration to rats, Pharmacol Toxicol, 69, 132, 10.1111/j.1600-0773.1991.tb01286.x Brown, 1977, Biotransformation and hepatotoxicity of halothane, Biochem Pharmacol, 26, 2091, 10.1016/0006-2952(77)90256-8 Byrne, 1994, Minocycline related lupus, Br J Rheum, 33, 674, 10.1093/rheumatology/33.7.674 Calabresi, 1996, Antineoplastic agents, 1202 Camilleri, 1984, Halothane aggrevation of chronic liver disease, Acta Medica Protuguesa, 5, 194 Campbell, 1977, Cholestatic liver disease associated with diphenylhydantoin therapy. Possible pathogenic importance of altered bile acid metabolism, Am J Dig Dis, 22, 255, 10.1007/BF01072286 Camuto, 1987, Long-term effects of etretinate on the liver in psoriasis, Am J Surg Path, 11, 30, 10.1097/00000478-198701000-00004 Carauna, 1983, Serum antibodies against double-stranded DNA in chronic active hepatitis: An index of drug-induced liver disease? (letter), Lancet, 1, 776, 10.1016/S0140-6736(83)92073-1 Chan, 1990, Dantrolene sodium and hepatic injury, Neurology, 40, 1427, 10.1212/WNL.40.9.1427 Cook, 1981, Phenytoin-induced granulomatous hepatitis, Aust N Z J Med, 11, 539, 10.1111/j.1445-5994.1981.tb04627.x Courty, 1985, Hepatitis associated with propylthiouracil treatment, Drug Intelligence and Clinical Pharmacology, 19, 740, 10.1177/106002808501901009 Cousins, 1979, Hepatotoxicity and halothane metabolism in an animal model with application for human toxicity, Anaesth Intens Care, 7, 9, 10.1177/0310057X7900700102 Deschamps, 1991, Inhibition by salicylic acid of the activation and thus oxidation of long chain fatty acids. Possible role in the development of Reye's syndrome, J Pharmacol Exp Ther, 259, 694 Devictor, 1992, Emergency liver transplantation for fulminant liver failure in infants and children, Hepatology, 16, 1156, 10.1002/hep.1840160509 Dickinson, 1981, Risk factors for isoniazid (INH)-induced liver dysfunction, J Clin Gastroenterol, 3, 271, 10.1097/00004836-198109000-00012 Dossing, 1993, Drug-induced hepatic disorders. Incidence, management and avoidance, Drug Saf, 9, 441, 10.2165/00002018-199309060-00007 Dykes, 1997, Is halothane hepatitis chronic active hepatitis? There may be a need to control the challenge test, Journal of Anesthesiology, 46, 233, 10.1097/00000542-197704000-00001 Elias, 1979, Chlorpromazine and it metabolites alter polymerization and gelatin of actin, Science, 206, 1404, 10.1126/science.574316 Ellard, 1978, The hepatotoxicity of isoniazid among rapid and slow acetylators of the drug, American Review of Respiratory Disease, 118, 628 Farrell, 1994, Drug-induced chronic active hepatitis, 413 Fedotin, 1975, Liver disease caused by propylthiouracil, Arch Intern Med, 135, 319, 10.1001/archinte.1975.00330020123017 Fidler, 1996, Chronic ecstacy (3,4-methylenededioxyamphetamine) abuse: A recurrent and severe cause of acute hepatitis, J Hepatol, 25, 563, 10.1016/S0168-8278(96)80217-0 Glazer, 1982, A study of potential hepatotoxicity of etretinate used in the treatment of psoriasis, J Am Acad Dermatol, 6, 683, 10.1016/S0190-9622(82)70057-X Goldstein, 1973, Drug-induced active chronic hepatitis, Dig Dis, 18, 177, 10.1007/BF01071970 Gough, 1996, Minocycline-induced autoimmune hepatitis and systemic lupus erythematosis-like syndrome, BMJ, 312, 169, 10.1136/bmj.312.7024.169 Graham, 1979, Isoniazid-related liver disease. Occurrence with portal hypertension, hypoalbuminemia and hypersplenism, JAMA, 242, 353, 10.1001/jama.1979.03300040039024 Gurumurthy, 1984, Lack of relationship between hepatic toxicity and acetylator phenotype in three thousand South Indian patients during treatment with isoniazid for tuberculosis, American Review of Respiratory Disease, 129, 58 Homberg, 1985, Drug-induced hepatitis associated with anticytoplasmic organell autoantibodies, Hepatology, 5, 722, 10.1002/hep.1840050504 Hoofnagle, 1995, Fulminant hepatic failure: Summary of a workshop, Hepatology, 21, 240 Horvath, 1978, Fine structural changes in the liver of methotrexate treated psoriatics, Digestion, 17, 488, 10.1159/000198155 Huwyler, 1992, Halothane metabolism. Impairment of hepatic omega-oxidation of leukotrienes in vivo and in vitro, Eur J Biochem, 206, 869, 10.1111/j.1432-1033.1992.tb16995.x Ivarson, 1979, Multiple attacks of jaundice associated with repeated sulfonamide treatment, Acta Medica Scandinavia, 206, 219, 10.1111/j.0954-6820.1979.tb13498.x Johnson, 1977, Chronic liver disease and acetominophen, Ann Intern Med, 87, 302, 10.7326/0003-4819-87-3-302 Kenna, 1988, Evidence for expression in human liver of halothane-induced neoantigens recognized by antibodies in sera from patients with halothane hepatitis, Hepatology, 8, 1635, 10.1002/hep.1840080627 Kenna, 1988, Metabolic basis for a drug hypersensitivity: Antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane, J Pharmacol Exp Ther, 245, 1103 King, 1990, Drug-induced cholestasis: Pathogenesis and clinical features, Semin Liv Dis, 10, 316, 10.1055/s-2008-1040487 Klatskin G: Toxic hepatitis. In Schiff L (ed): Diseases of the Liver, ed 1. Philadelphia, JB Lippincott, pp 328–394 Kobayashi, 1995, Severe chronic active hepatitis induced by UFT containing Tegufur and Uracil, Dig Dis Sci, 40, 2434, 10.1007/BF02063250 Kowdley, 1992, Prolonged cholestasis due to trimethoprim-sulfamethoxazole, Gastroenterology, 102, 2148, 10.1016/0016-5085(92)90346-Z Kretz-Rommel, 1993, Diclofenac covalent protein binding is dependent on acyl glucuronide formation and is inversely related to P-450-mediated acute cell injury in culture rat hepatocytes, Toxicol Appl Pharmacol, 120, 155, 10.1006/taap.1993.1097 Kronborg, 1983, Chronic hepatitis after successive halothane anesthetics, Digestion, 27, 123, 10.1159/000198941 Larrey, 1992, Hepatitis after germander (teucrium chamaedrys) administration: Another instance of herbal medicine hepatotoxicity, Ann Intern Med, 117, 129, 10.7326/0003-4819-117-2-129 Lewis, 1989, Drug-induced liver disease, Med Clin North Am, 73, 775, 10.1016/S0025-7125(16)30638-1 Lewis JH, Zimmerman HJ: Drug-induced autoimmune liver disease. (In press) Lewis, 1991, Assessment and treatment of acetominophen overdose, Clin Pharm, 10, 765 Maggiore, 1989, Propylthiouracil hepatotoxicity mimicking autoimmune chronic hepatitis in a girl, J Pediatr Gastroenterol, 8, 547, 10.1097/00005176-198905000-00025 Malcolm, 1996, Minocycline-induced liver injury, Am J Gastroenterol, 91, 1641 Maruyama, 1995, Chronic active hepatitis and liver cirrhosis in association with combined tamoxifen/tegafur adjuvant therapy, Dig Dis Sci, 40, 2602, 10.1007/BF02220448 Mitchell, 1974, Massive hepatic necrosis caused by furosemide, Nature, 251, 508, 10.1038/251508a0 Mitchell, 1975, Metabolic activation of drugs to toxic substances, Gastroenterology, 68, 392, 10.1016/S0016-5085(75)80025-4 Mitchell, 1975, Acetylation rates and monthly liver function tests during 1 year of isoniazid preventive therapy, Chest, 68, 181, 10.1378/chest.68.2.181 Mitchell, 1975, Increased incidence of isoniazid hepatitis in rapid acetylators: Possible relation to hydrazine metabolites, Clin Pharmacol Ther, 18, 70, 10.1002/cpt197518170 Mitchell, 1976, Isoniazid liver injury: Clinical spectrum, pathology and probable pathogenesis, Ann Intern Med, 84, 181, 10.7326/0003-4819-84-2-181 Mollison, 1992, Hepatitis due to nitrofurantoin, Med J Aust, 156, 347, 10.5694/j.1326-5377.1992.tb139795.x Moreno, 1984, Reduction of nifurtimox and nitrofurantoin to free radical metabolites by rat liver mitochondria. Evidence of an outer membrane-located nitroreductase, J Biol Chem, 259, 6298, 10.1016/S0021-9258(20)82140-1 Mullick, 1980, Hepatic injury associated with diphenylhydantoin therapy: A clinicopathologic study of 20 cases, Am J Clin Path, 74, 442, 10.1093/ajcp/74.4.442 Munthe, 1949, On protein uptake, hepatitis an consumption of laxatives, Acta Med Scan Suppl, 234, 125 Myers, 1957, Xanthomatous biliary cirrhosis following chlorpromazine, with observations indicating overproduction of cholesterol, hyperprothormbinemia and the development of portal hypertension, Trans Assoc Am Physicians, 70, 243 Nastainczyk, 1978, Effects of oxygen concentration on the reaction of halothane with cytochrome P-450 in liver microsomes and isolated perfused rat liver, Biochem Pharm, 27, 387, 10.1016/0006-2952(78)90366-0 Nelis, 1981, Unique metabolic fate of a tetracycline (minocycline) (letter), Lancet, 938, 10.1016/S0140-6736(81)91426-4 Nelson, 1990, Molecular mechanisms of the hepatotoxicity caused by acetominophen, Semin Liv Dis, 10, 267, 10.1055/s-2008-1040482 Nelson, 1976, Isoniazid and iproniazid: Activation of metabolites to toxic intermediates in man and rat, Science, 193, 901, 10.1126/science.7838 Neuberger, 1990, Halothane and hepatitis. Incidence, predisposing factors and exposure guidelines, Drug Saf, 5, 28, 10.2165/00002018-199005010-00004 Neuberger, 1987, Halothane hepatitis: A model of immune mediated drug hepatotoxicity, Clin Sci, 72, 263, 10.1042/cs0720263 Neuberger, 1985, Antibody mediated hepatocyte injury in methyldopa induced hepatotoxicity, Gut, 261, 1233, 10.1136/gut.26.11.1233 Neuberger, 1989, Immune mechanisms in tienilic acid associated hepatotoxicity, Gut, 30, 515, 10.1136/gut.30.4.515 Nyfors, 1977, Liver ultrastructure in psoriatics related to methotrexate therapy. 1. A prospective study of findings in hepatocytes from 24 patients before and after methotrexate treatment, Acta Pathol Microbiol Scand, 85, 787 Olumu, 1988, High incidence of poor sulfoxidation in patients with primary biliary cirrhosis, N Engl J Med, 318, 1089, 10.1056/NEJM198804283181703 Pariente, 1989, Clometacin hepatitis. Retrospective study of 30 cases, A model of drug induced autoimmune hepatitis? Gastroenterol Clin Biol, 13, 769 Parker, 1982, Propylthiouracil-induced hepatotoxicity, Clin Pharm, 1, 471 Pohl, 1990, Drug-induced allergic hepatitis, Semin Liv Dis, 10, 305, 10.1055/s-2008-1040486 Pohl, 1989, Drug-induced allergic hepatitis. Does isaxonine fall into this category, Hepatology, 9, 785, 10.1002/hep.1840090519 Pohl, 1982, A perspective on halothane-induced hepatotoxicity, Anesth Analg, 61, 809, 10.1213/00000539-198210000-00001 Pohl, 1989, Neoantigens associated with halothane hepatitis, Drug Metab Rev, 20, 203, 10.3109/03602538909103537 Reynolds, 1970, Puzzling jaundice, probable relationship to laxative ingestion, JAMA, 211, 86, 10.1001/jama.1970.03170010040007 Reynolds, 1971, Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin, N Engl J Med, 285, 813, 10.1056/NEJM197110072851501 Roy, 1993, Phenytoin-induced chronic hepatitis, Dig Dis Sci, 38, 740, 10.1007/BF01316808 Roy, 1980, Lymphocyte sensitization in nifedipine-induced hepatitis, Res Comm Chem Path Pharm, 27, 507 Sallie, 1991, Diclofenac hepatitis, Aus N Z J Med, 21, 251, 10.1111/j.1445-5994.1991.tb00455.x Sanchez, 1993, Retinoid hepatitis, J Am Acad Dermatol, 28, 853, 10.1016/0190-9622(93)70117-C Schweitzer, 1974, Acute submassive hepatic necrosis due to methyldopa: A case demonstrating possible initiation of chronic liver disease, Gastroenterology, 66, 1203, 10.1016/S0016-5085(74)80013-2 Scully, 1993, Diclofenac-induced hepatitis: 3 cases with features of autoimmune chronic active hepatitis, Dig Dis Sci, 38, 744, 10.1007/BF01316809 Seaman, 1974, Aspirin-induced hepatotoxicity in patients with systemic lupus erythematosus, Ann Intern Med, 80, 1, 10.7326/0003-4819-80-1-1 Seeff, 1981, Drug-induced chronic liver disease, with emphasis on chronic active hepatitis, Sem Liv Dis, 1, 104, 10.1055/s-2008-1040723 Seeff, 1986, Acetaminophen hepatotoxicity in alcoholics, A therapeutic misadventure, Ann Intern Med, 104, 399, 10.7326/0003-4819-104-3-399 Seeff LB: Chronic drug-induced liver disease. George Washington Gastroenterology Board Review course. Selroos, 1975, Lupus-like syndrome associated with pulmonary reaction to nitrofurantoin, Acta Med Scand, 197, 125, 10.1111/j.0954-6820.1975.tb04889.x Spechler, 1981, Cholestasis and tocic epidermal necrolysis associated with phenytoin sodium ingestion: The role of bile duct injury, Ann Intern Med, 95, 455, 10.7326/0003-4819-95-4-455 Spielberg, 1981, Predisposition to phenytoin hepatotoxicity assessed in vitro, N Engl J Med, 305, 722, 10.1056/NEJM198109243051302 Spielberg, 1989, Nitrofurantoin cytotoxicity. In vitro assessment of risk based on glutathione metabolism, J Clin Invest, 67, 37, 10.1172/JCI110030 Stricker, 1988, Hepatic injury associated with the use of nitrofuransL a clinicopathological study of 52 reported cases, Hepatology, 8, 599, 10.1002/hep.1840080327 1992, 1 Thirumoorthy, 1988, Adverse hepatic reactions associated with etretinate in patients with psoriasis-analysis of 22 cases, Ann Acad Med, 17, 477 Thomas, 1974, Chronic aggressive hepatitis induced by halothane, Ann Intern Med, 81, 487, 10.7326/0003-4819-81-4-487 Thomas, 1993, Paracetamol (acetominophen) poisoning, Pharmacol Ther, 60, 91, 10.1016/0163-7258(93)90023-7 Tisdale, 1958, Focal hepatitis, fever and skin rash following therapy with sulfamethoxypyridazine, long-acting sulfonamide, N Engl J Med, 258, 687, 10.1056/NEJM195804032581404 Tolman, 1980, Nitrofurantoin and chronic active hepatitis (letter), Ann Intern Med, 92, 119, 10.7326/0003-4819-92-1-119 Tonder, 1974, Sulfonamide-induced chronic liver disease, Scand J Gastroenterol, 19, 93, 10.1080/00365521.1974.12096796 Utili, 1977, Dantrolene-associated hepatic injury, Gastroenterology, 72, 610, 10.1016/S0016-5085(77)80141-8 Van Dyke, 1987, Effects of chlorpromazine on Na+ − K+-ATPase pumping and solute transport in rat hepatocytes, Am J Physiol, 253, G613 van Voorst Vader, 1984, Etretinate (Tigason) hepatitis in 2 patients, Dermatologica, 168, 41, 10.1159/000249664 Vermeulen, 1992, Molecular aspects of paracetamol-induced hepatotoxicity and its mechanism-based prevention, Drug Metab Rev, 24, 367, 10.3109/03602539208996298 Watkins, 1990, Role of cytochromes P-450 in drug metabolism and hepatotoxicity, Semin Liv Dis, 10, 235, 10.1055/s-2008-1040480 Watson, 1988, A proposed mechanism for chlorpromazine jaundice - defective hepatic sulphoxidation combined with rapid hydroxylation, J Hepatol, 7, 72, 10.1016/S0168-8278(88)80508-7 Weinstein, 1973, Psoriasis-liver-methotrexate interactions: Co-operative study, Arch Derm, 108, 36, 10.1001/archderm.1973.01620220008002 Whiting-O'Keefe, 1991, Methotrexate and histologic hepatic abnormalities: A meta-analysis, Am J Med, 90, 711, 10.1016/S0002-9343(05)80060-9 Wilkinson, 1979, Hepatitis from dantrolene sodium, Gut, 20, 33, 10.1136/gut.20.1.33 Zimmerman, 1990, Update of hepatotoxicity due to classes of drugs in common clinical use: Non-steroidal drugs, anti-inflammatory drugs, antibiotics, antihypertensives, and cardiac and psychotropic agents, Sem Liv Dis, 10, 322, 10.1055/s-2008-1040488 Zimmerman, 1984, Ticrynafen-associated hepatic injury: Analysis of 340 cases, Hepatology, 4, 315, 10.1002/hep.1840040223 Zimmerman, 1981, Effects of aspirin and acetaminophen on the liver, Arch Intern Med, 141, 333, 10.1001/archinte.1981.00340030065013